Dr Cédric Duval
- Position: Postdoctoral Research Fellow
- Areas of expertise: Cardiovascular Disease; Thrombosis; Coagulation; Fibrinogen; Factor XIII
- Email: C.Duval@leeds.ac.uk
- Location: Discovery and Translational Science Department Leeds Institute of Cardiovascular And Metabolic Medicine
- Website: Publons | LinkedIn | Researchgate | ORCID
I have studied Physiology and Molecular Biology at undergraduate level at the University of Rennes (France), before moving to Nice to undertake and MRes in Cellular Biology and Physiology, where I spent time performing research at the University of Newcastle upon Tyne.
I followed this with a 4-year Wellcome Trust PhD programme in Cellular and Molecular Physiology, at the University of Liverpool. Two short-term postdoctoral position followed, studying the effect of H. pylori on the development of gastric cancer, both in Liverpool and Leeds.
I then opted to move into the cardiovascular field, working with Prof Robert Ariëns (2010 onwards), focussing on the roles of Fibrinogen and Factor XIII in the aethiology of thrombosis.
Outside work, I am a keen long-distance runner and do some volunteering in the form of school governor, and official on a couple of football governing bodies.
- LIGHT Laboratories Organisational Group for Information and Communication (LOGIC) co-Chair
- LICAMM Buildings and Facilities User Group Representative
Molecular mechanisms in haemostasis and thrombosis
My research focuses on understanding the mechanisms involved in haemostasis and thrombosis. In particular, I am focusing on understanding the role of fibrinogen and coagulation factor (F)XIII in fibrin clot structure and thrombosis.
Cardiovascular disease (CVD), is the most common cause of morbidity and mortality in the Western World. In Europe alone, it is responsible for 4.3 million deaths per year and as much as 35% of all deaths in the UK are attributed to CVD. The development of a thrombus in CVD patients is the ultimate cause of death. The role of the fibrin clot itself is poorly defined in relation to thrombus formation and thrombolysis.
My research aims to elucidate: 1)The roles of the different fibrinogen chains in clot formation and stabilisation, and ultimately their roles in thrombosis. 2) The role of FXIII cross-linking within the clot in clot formation, stability, and ultimately in thrombosis.
Most of the methods used in these projects range from molecular biology (generation and expression of recombinant proteins) to biochemistry (purification and analysis of proteins), biophysics (atomic force microscopy, confocal and electron microscopy, magnetic tweezers), and in-vivo studies.
British Heart Foundation Programme Grant, £1,323,069; 2019-2024, RG/18/11/34036. Role of fibrin biofilm and clot network architecture in thrombus stability. Awarded to RAS Ariëns, NY Yuldasheva, SD Connell, VC Ridger, JP Greenwood, RA Ajjan, H Philippou
Medical Research Council Genome Editing Mice for Medicine Award, circa £55,000; 2018-2020. Generation of a FGA-4X murine model: Role of fibrin alpha-chain cross-linking in fibrin clot stability and thrombosis. Awarded to C Duval, RAS Ariëns
Medical Research Council Genome Editing Mice for Medicine Award, circa £55,000; 2016-2018. Generation of FXIIIA-34Val murine model: Role in atherothrombosis and venous thromboembolism. Awarded to C Duval, RAS Ariëns
British Heart Foundation PhD Studentship, £107,059; 2015-18, FS/15/37/31513. Role of extended knob-hole interaction sites in fibrin polymerisation and clot stability. Awarded to MM Domingues, C Duval, RAS Ariëns
British Heart Foundation Programme Grant, £1,145,224; 2013-2018, RG/13/3/30104. Mechanisms of fibrin structure in thrombosis. Awarded to RAS Ariëns, H Philippou, SD Connell, R Ajjan, VC Ridger.
Medical Research Council Project Grant, £400,000; 2010-2013, G0901546. Role of coagulation factor XIII in fibrin clot structure and thrombosis. Awarded to RAS Ariëns, H Philippou, VC Ridger.
- PhD in Gastric Cellular and Molecular Physiology (University of Liverpool)
- MRes in Cellular and Molecular Physiology (University of Liverpool)
- Diplôme d’Études Approfondies (MRes) in Cellular Biology and Physiology (University of Nice, France)
- Maîtrise (MSc) in Cellular Biology and Physiology, (University of Rennes, France)
- Licence (BSc) in Cellular Biology and Physiology (University of Rennes, France)
- Associate Fellow of the Higher Education Academy
- Member of the ISTH (International Society on Thrombosis and Haemostasis)
- Member of the BSHT (British Society for Haemostasis and Thrombosis)
Adomas Baranauskas (2016-19): Understanding the role of coagulation Factor XIII in the development of venous and arterial thrombosis.
Nathan Asquith (2015-18): Role of extended knob-hole interaction sites in fibrin polymerisation and clot stability. Thesis successfully defended December 2018. Next Position: Postdoctoral Researcher at Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA (Dr Italiano).
Aliaa Sabban (2015-18): Characterisation of the erythrocyte binding site on fibrinogen; Implications for clot structure and thrombosis.
Medicine Intercalated BSc supervisor
Matthew Gold (Medicine Intercalated BSc, 2016/17): Role of Fibrinogen alpha-chain in fibrin clot formation, structure and stability.
Eloisa MacLachlan (Medicine Intercalated BSc, 2015/16): The development of novel murine tools to study the role of FXIII V34L in thrombosis.
Thomas Riley (Medicine Intercalated BSc, 2014/15): Effects of fibrinogen gamma’ peptides on clot structure and stability.
Christina Hitchen (Medicine Intercalated BSc, 2013/14): Effects of Fibrinogen gamma' on structure and stability of blood clots.
Waleed Chaudhry (Medicine Intercalated BSc, 2012/13): Kinetics of Factor XIII activation and fibrin clot structure.
Lecturer and Tutor in other Undergraduate Medical Programmes
Research groups and institutes
- Leeds Institute of Cardiovascular and Metabolic Medicine
- Discovery and Translational Science